Activation of vascular endothelial growth factor receptor-3 in macrophages restrains TLR4-NF-κB signaling and protects against endotoxin shock

Immunity

Volumn 40, Issue 4, 2014, Pages 501-514

  Zhang, Yanbo ^a   Lu, Yao ^a   Ma, Li ^a   Cao, Xudong ^b   Xiao, Jun ^a   Chen, Jiexia ^c   Jiao, Shaozhuo ^a   Gao, Yunzhen ^a   Liu, Chang ^a   Duan, Zhaojun ^d   Li, Dangsheng ^e   He, Yulong ^b   Wei, Bin ^a   Wang, Hongyan ^a,f  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

^d National Institute for Viral Disease Control and Prevention   (China)

^e Chinese Academy of Sciences   (China)

^f INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-NEGATIVE ANAEROBIC BACTERIA; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SHOCK, SEPTIC; SIGNAL TRANSDUCTION; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TOLL-LIKE RECEPTOR 4; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84898797252     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.01.013     Document Type: Article

References (51)

1. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 2007, 8:464-478.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Aksoy E., Taboubi S., Torres D., Delbauve S., Hachani A., Whitehead M.A., Pearce W.P., Berenjeno I.M., Nock G., Filloux A., et al. The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat. Immunol. 2012, 13:1045-1054.
4. Alitalo K., Tammela T., Petrova T.V. Lymphangiogenesis in development and human disease. Nature 2005, 438:946-953.
5. Androulidaki A., Iliopoulos D., Arranz A., Doxaki C., Schworer S., Zacharioudaki V., Margioris A.N., Tsichlis P.N., Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009, 31:220-231.
6. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
7. Burke J.E., Vadas O., Berndt A., Finegan T., Perisic O., Williams R.L. Dynamics of the phosphoinositide 3-kinase p110δ interaction with p85α and membranes reveals aspects of regulation distinct from p110α. Structure 2011, 19:1127-1137.
8. Dixelius J., Makinen T., Wirzenius M., Karkkainen M.J., Wernstedt C., Alitalo K., Claesson-Welsh L. Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J.Biol. Chem. 2003, 278:40973-40979.
9. Du Z., Wei L., Murti A., Pfeffer S.R., Fan M., Yang C.H., Pfeffer L.M. Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway. J.Cell. Biochem. 2007, 102:1087-1094.
10. Dumont D.J., Jussila L., Taipale J., Lymboussaki A., Mustonen T., Pajusola K., Breitman M., Alitalo K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998, 282:946-949.
11. Evel-Kabler K., Song X.T., Aldrich M., Huang X.F., Chen S.Y. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J.Clin. Invest. 2006, 116:90-100.
12. Guha M., Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J.Biol. Chem. 2002, 277:32124-32132.
13. Harrison C. Sepsis: calming the cytokine storm. Nat. Rev. Drug Discov. 2010, 9:360-361.
14. Haxhinasto S., Mathis D., Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J.Exp. Med. 2008, 205:565-574.
15. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A.E., Kel O.V., Ignatieva E.V., Ananko E.A., Podkolodnaya O.A., Kolpakov F.A., et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 1998, 26:362-367.
16. Huggenberger R., Siddiqui S.S., Brander D., Ullmann S., Zimmermann K., Antsiferova M., Werner S., Alitalo K., Detmar M. An important role of lymphatic vessel activation in limiting acute inflammation. Blood 2011, 117:4667-4678.
17. Karkkainen M.J., Petrova T.V. Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 2000, 19:5598-5605.
18. Karkkainen M.J., Ferrell R.E., Lawrence E.C., Kimak M.A., Levinson K.L., McTigue M.A., Alitalo K., Finegold D.N. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat. Genet. 2000, 25:153-159.
19. Karkkainen M.J., Saaristo A., Jussila L., Karila K.A., Lawrence E.C., Pajusola K., Bueler H., Eichmann A., Kauppinen R., Kettunen M.I., et al. A model for gene therapy of human hereditary lymphedema. Proc. Natl. Acad. Sci. USA 2001, 98:12677-12682.
20. Karkkainen M.J., Haiko P., Sainio K., Partanen J., Taipale J., Petrova T.V., Jeltsch M., Jackson D.G., Talikka M., Rauvala H., et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 2004, 5:74-80.
21. Kataru R.P., Jung K., Jang C., Yang H., Schwendener R.A., Baik J.E., Han S.H., Alitalo K., Koh G.Y. Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009, 113:5650-5659.
22. Keck S., Freudenberg M., Huber M. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J.Immunol. 2010, 184:5809-5818.
23. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002, 17:583-591.
24. Kirkin V., Thiele W., Baumann P., Mazitschek R., Rohde K., Fellbrich G., Weich H., Waltenberger J., Giannis A., Sleeman J.P. MAZ51, an indolinone that inhibits endothelial cell and tumor cell growth invitro, suppresses tumor growth invivo. Int. J. Cancer 2004, 112:986-993.
25. Kondo T., Kawai T., Akira S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 2012, 33:449-458.
26. Kukk E., Lymboussaki A., Taira S., Kaipainen A., Jeltsch M., Joukov V., Alitalo K. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996, 122:3829-3837.
27. Laakkonen P., Waltari M., Holopainen T., Takahashi T., Pytowski B., Steiner P., Hicklin D., Persaud K., Tonra J.R., Witte L., Alitalo K. Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res. 2007, 67:593-599.
28. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation oftoll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
29. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009, 21:154-165.
30. Lundberg A.M., Drexler S.K., Monaco C., Williams L.M., Sacre S.M., Feldmann M., Foxwell B.M. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 2007, 110:3245-3252.
31. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'Neill L.A., Hertzog P.J. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 2006, 7:148-155.
32. Martin M., Rehani K., Jope R.S., Michalek S.M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 2005, 6:777-784.
33. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17:677-687.
34. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J.Immunol. 2000, 164:3476-3479.
35. Olsson A.K., Dimberg A., Kreuger J., Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 2006, 7:359-371.
36. Park S.H., Park-Min K.H., Chen J., Hu X., Ivashkiv L.B. Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat. Immunol. 2011, 12:607-615.
37. Patton D.T., Garden O.A., Pearce W.P., Clough L.E., Monk C.R., Leung E., Rowan W.C., Sancho S., Walker L.S.K., Vanhaesebroeck B., Okkenhaug K. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory Tcells. J.Immunol. 2006, 177:6598-6602.
38. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit. Care 2010, 14:R15.
39. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
40. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z.A., Cobb B.S., Cantrell D., O'Connor E., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 2008, 105:7797-7802.
41. Sun D., Ding A. MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA. Nat. Immunol. 2006, 7:375-381.
42. Sun S.C., Ley S.C. New insights into NF-kappaB regulation and function. Trends Immunol. 2008, 29:469-478.
43. Takahashi R., Nishimoto S., Muto G., Sekiya T., Tamiya T., Kimura A., Morita R., Asakawa M., Chinen T., Yoshimura A. SOCS1 isessential for regulatory Tcell functions by preventing loss of Foxp3 expression as well as IFN-gamma and IL-17A production. J.Exp. Med. 2011, 208:2055-2067.
44. Takaoka A., Mitani Y., Suemori H., Sato M., Yokochi T., Noguchi S., Tanaka N., Taniguchi T. Cross talk between interferon-gamma and -alpha/beta signaling components in caveolar membrane domains. Science 2000, 288:2357-2360.
45. Tammela T., Saaristo A., Holopainen T., Lyytikkä J., Kotronen A., Pitkonen M., Abo-Ramadan U., Ylä-Herttuala S., Petrova T.V., Alitalo K. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat. Med. 2007, 13:1458-1466.
46. Tidswell M., Tillis W., Larosa S.P., Lynn M., Wittek A.E., Kao R., Wheeler J., Gogate J., Opal S.M. Phase 2 trial of eritoran tetrasodium (E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit. Care Med. 2010, 38:72-83. Eritoran Sepsis Study Group.
47. van der Flier M., van Leeuwen H.J., van Kessel K.P., Kimpen J.L., Hoepelman A.I., Geelen S.P. Plasma vascular endothelial growth factor in severe sepsis. Shock 2005, 23:35-38.
48. West A.P., Koblansky A.A., Ghosh S. Recognition and signaling by toll-like receptors. Annu. Rev. Cell Dev. Biol. 2006, 22:409-437.
49. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Schweitzer J., Vogt W., Browder I.W. Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality. Crit. Care Med. 2003, 31:1808-1818.
50. Yano K., Liaw P.C., Mullington J.M., Shih S.C., Okada H., Bodyak N., Kang P.M., Toltl L., Belikoff B., Buras J., et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J.Exp. Med. 2006, 203:1447-1458.
51. Zhang L., Zhou F., Han W., Shen B., Luo J., Shibuya M., He Y. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis. Cell Res. 2010, 20:1319-1331.